Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03089034

Singapore Cohort of Patients with Advanced Heart Failure

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Duke-NUS Graduate Medical School · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

Chronic Heart Failure (CHF) is one of the leading causes of death in Singapore. Although it is well established that CHF patients in Singapore are less likely to be referred to palliative care services than cancer patients, little data is available on end-of-life (EOL) experience of advanced CHF patients in Singapore, including the inter-relationships between patient decision-making, quality of life trajectories, and health and cost consequences.

Detailed description

To address this gap and to identify areas for better delivery of end-of-life services to patients with advanced CHF, the investigators propose to enrol a cohort of 300 patients with advanced CHF (New York Heart Association class III and IV), survey the participants every 4 months for a period of two years or till they die, whichever is earlier. The goal of this cohort study is to better understand the relationship between patient preferences, health care access, utilization, costs, and quality of life, and to identify strategies to improve the EOL experience for these patients. It is also important to recognize the significant role of the family in medical decision making in Asia. Previous studies from Singapore reveal that patients want their families to be involved in the decision making process. The role of the family in decision making is consistent with the Chinese culture of interdependency, obligations and filial piety. Decisions regarding treatment are often made by family caregivers, sometimes with little or no input from patients. Given this reality, the investigators will also enroll caregivers of the patients to evaluate their role in decision making for treatment of patients.

Conditions

Timeline

Start date
2017-07-24
Primary completion
2025-10-31
Completion
2025-10-31
First posted
2017-03-24
Last updated
2025-02-05

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT03089034. Inclusion in this directory is not an endorsement.